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Letter to the Editor
Prospective Metanalysis Within Complementary
Medicine Research
Dawn-Marie WalkerAU1c
Dear Editor:
It appears that medical research funders are reluctant to
provide sufficient funding to allow fully powered random-
ized control trials (RCTs) within the field of complementary
medicine (CM). Funders often state that there is no evidence
base to make the decision concerning whether to award such
a grant. Our research area is awash with promising, but not
fully powered data or lower-level noncontrolled data. This
lack of efficacy resulting from problems involving trying to
apply the ‘‘gold standard’’ of RCTs results in health organi-
zations not integrating CM into health care provision, re-
gardless of patients’ opinions.
Health organizations base many of their guidelines on
what they regard as the top level of evidence (i.e., systematic
reviews [SRs]), which are regarded as the gold standard of
evidence by health care policymakers. SRs are thorough lit-
erature searches that incorporate methods (e.g., inclusion
criteria) to prevent bias. Usually, SRs are based on the results
from RCTs, such as the ones adopted by the Cochrane Col-
laboration, although there are moves to develop methodol-
ogies to systemize reviews of other, non-RCT articles, such
being able to include cohort or qualitative papers. Examples
of these articles would include as the work by the Campbell
Collaboration or the Joanna Briggs Institute. However, even
with these developments, policymakers are loath to supply
therapies without support from fully powered RCT trials.
One benefit of SRs is that data from different trials re-
ported in the included articles, if using a common measure of
effect size, can be amalgamated using meta-analysis (MA).
The results from an MA are more powerful estimates of the
true effect size than those derived from a single trial because
the MA is based on different trials, crossing geographical
boundaries, populations, trial conduct, etc. As a MA pools
data, it also results in a larger overall sample size because the
MA includes populations from all of the included trials,
therefore reaching higher statistical power to detect an effect.
Although this type of analysis lends itself to complementary
and alternative medicine (CAM) research, as many trials
reported are small-scale, often, an MA cannot be conducted
on the data obtained from included articles because such
studies are often heterogeneous. One way that this can be
overcome in CAM research is by collaborating using a pro-
spective MA (PMA) design. In a PMA, trials are identified,
evaluated, and determined prior to publication to establish
eligibility for a post-trial MA, therefore, allowing pre-
standardization of information required for the post-hoc MA.
The PMA is a way of building the CAM evidence base in the
absence of being able to conduct large, full-scale trials.
Arguably, this approach takes more organizing and col-
laboration at a very early stage in research. This may take the
form of liaising with other researchers within a discipline,
nationally and internationally, to write the protocol initially,
and having maintenance meetings to ensure a continuum of
a study protocol. Any divergence from protocol for any
reason would be discussed with the PMA group. However,
in the absence of funders giving large grants to run fully
powered RCTs to explore the efficacy of complementary
therapies, I believe that this is the only way forward in
forming an evidence base. A good resource for researchers
who are interested in this methodology can be found here:
Ghersi D, Berlin J, Askie L on behalf of the Cochrane
Prospective Meta-Analysis Methods Group. Pro-
spective meta-analysis. In Higgins JPT, Green S, eds.
Cochrane Handbook for Systematic Reviews of Inter-
ventions Version 5.0.0 [updated February 2008]. The
Cochrane Collaboration 2008. Online document at:
www.cochrane-handbook.org
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